AVR anteris technologies global corp.

Ann: Admedus Releases Results of HSV-2 Phase IIa Study, page-147

  1. 1,338 Posts.
    lightbulb Created with Sketch. 58
    I hope Eath comes back on to explain to you all the significance of the trial.
    It's all to do about
    1/where this trial sits in the overall development of a potential vaccine and
    2/ the statistical significance of the results (it's power was small because of the small number of participants) .. but that has to do with point 1/)
    and
    3/ the costs of taking it further.

    Listen to what he says about it OK?
    Last edited by jaygatsby: 04/05/17
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$8.34
Change
0.150(1.83%)
Mkt cap ! $119.8M
Open High Low Value Volume
$8.19 $8.34 $8.10 $23.15K 2.839K

Buyers (Bids)

No. Vol. Price($)
6 690 $8.12
 

Sellers (Offers)

Price($) Vol. No.
$8.34 126 1
View Market Depth
Last trade - 11.06am 18/09/2025 (20 minute delay) ?
AVR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.